ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification and experimental validation of a tumor-infiltrating lymphocytes-related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma

Deng, Yulin; Guo, Kai; Tang, Zhenfeng; Feng, Yuanfa; Cai, Shanghua; Ye, Jianheng; Xi, Yuanxue; Li, Jinchuang; Liu, Ren; Cai, Chao; Tan, Zeheng; Zhang, Yixun; Han, Zhaodong*; Zeng, Guohua*; Zhong, Weide*广州医学院; 南方医科大学; 1
Frontiers in Immunology2022-11-24DOI: 10.3389/fimmu.2022.1046790
3被引14阅读
引用收藏
分享

摘要

Clear cell renal cell carcinoma (ccRCC) is a common aggressive malignant tumor of the urinary system. Given the heterogeneity of the tumor microenvironment, immunotherapy may not fully exert its role in the treatment of advanced patients. Long noncoding RNA (lncRNA) has been reported to be critically associated with the differentiation and maturation of tumor-infiltrating lymphocytes (TILs), which work against tumor cells. In this study, we identified 10 TIL-related lncRNAs (AL590094.1, LINC02027, LINC00460, AC147651.1, AC026401.3, LINC00944, LINC01615, AP000439.2, AL162586.1, and AC084876.1) by Pearson correlation, univariate Cox regression, Lasso regression, and multivariate Cox regression based on The Cancer Genome Atlas (TCGA) database. A risk score model was established based on these lncRNAs. Next, a nomogram was constructed to predict the overall survival. By employing differentially expressed genes (DEGs) between groups with high and low risk scores, gene ontology (GO) enrichment analysis was performed to identify the major biological processes (BP) related to immune DEGs. We analyzed the mutation data of the groups and demonstrated that SETD2 and BAP1 had the highest mutation frequency in the high-risk group. The "CIBERSORT" R package was used to detect the abundance of TILs in the groups. The expression of lymphocyte markers was compared. We also determined the expression of two lncRNAs (AC084876.1 and AC026401.3) and their relationship with lymphocyte markers in the kidney tissue of ccRCC patients and showed that there was a positive correlation between AC084876.1 and FoxP3. Proliferation, migration, and invasion of AC084876.1-downregulated ccRCC cell lines were inhibited, and the expression of PD-L1 and TGF-beta secretion decreased. To our knowledge, this is the first bioinformatics study to establish a prognostic model for ccRCC using TIL-related lncRNAs. These lncRNAs were associated with T-cell activities and may serve as biomarkers of disease prognosis.

学科与关键词

关键词
tumor-infiltrating lymphocyteslong noncoding RNAbioinformaticsclear cell renal cell carcinomaprognostic
相关
加载中…
  • A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma
    Zhang, Zedan; Tang, Yanlin; Liu, Yanjun; Zhuang, Hongkai; Lin, Enyu; Xie, Lu; Feng, Xiaoqiang; Tian, Kaiwen; Zeng, Jiayi; Liu, Jiumin; Yu, Yuming*Journal of Immunology Research, 2021, 2021: 9921466.被引 10
  • Identification and Verification of Immune Subtype-Related lncRNAs in Clear Cell Renal Cell Carcinoma
    Wang, Zhifeng; Chen, Zihao; Guo, Tengyun; Hou, Menglin; Wang, Junpeng; Guo, Yanping; Du, Tao; Zhang, Xiaoli; Wang, Ning; Ding, Degang*; Li, Xiqing*Frontiers in Oncology, 2022, 12: 888502.被引 3
  • Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma
    Wei, Shi-Yao; Feng, Bei; Bi, Min; Guo, Hai-Ying; Ning, Shang-Wei*; Cui, Rui*BMC Medical Genomics, 2022, 15(1): 263.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-11-24
卷期
第 13 卷
页码
1046790
DOI
10.3389/fimmu.2022.1046790
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82072813]; Guangdong Basic and Applied Basic Research Foundation [2017A030310100, 2020A1515110792, 2022A1515010342]; Science and Technology Projects in Guangzhou [2020A1515110792]; Science and Technology Development Fund of Macau SAR [0031/2021/A]; Emergency Key Program of Guangzhou Laboratory [EKPG21-04]

作者

  • D

    Deng, Yulin (第一作者)

    1 · guangzhou med univ

  • G

    Guo, Kai

    southern med univ

查看全部 15 位作者收起作者
  • T

    Tang, Zhenfeng

    1 · guangzhou med univ

  • F

    Feng, Yuanfa

    1 · guangzhou med univ

  • C

    Cai, Shanghua

    guangzhou med univ · 1

  • Y

    Ye, Jianheng

    1

  • X

    Xi, Yuanxue

    1

  • L

    Li, Jinchuang

    1

  • L

    Liu, Ren

    1

  • C

    Cai, Chao

    1 · guangzhou med univ

  • T

    Tan, Zeheng

    southern med univ

  • Z

    Zhang, Yixun

    1

  • H

    Han, Zhaodong (通讯)

    1

  • Z

    Zeng, Guohua (通讯)

    1 · guangzhou med univ

  • Z

    Zhong, Weide (通讯)

    guangzhou med univ · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417